Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	85.56	52.23	28.15
Graham Fair Price	-51.59	110.63	228.54
PEG	-149.89	-1.26	-0.51
Price/Book	-3.06	1.33	1.37
Price/Cash Flow	409.08	126.20	24.79
Prices/Earnings	309.33	97.36	23.79
Price/Sales	11.04	5.91	5.32
Price/FCF	409.08	126.20	24.79
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-19.21	0.32	0.40
Operating Margin	-23.04	0.07	0.09
ROA	-76.15	< 0.005	< 0.005
ROE	0.01	< 0.005	-76.32
ROIC	0.01	< 0.005	-60.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.24	< 0.005	4775.75
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.33	-0.34	-4.36
EPS QOQ	-0.47	-0.77	-63.80
FCF QOQ	0.27	-0.81	204.69
Revenue QOQ	0.16	-0.15	-6.58
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-64.87	15.26	-76.48
Days Sales Outstanding (DSO)	52.79	27.95	-47.06
Inventory Turnover	-1.39	5.90	325.15
Debt/Capitalization	0.14	0.15	7.68
Quick Ratio	1.71	1.59	-6.90
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	401.47	399.35	-0.53
Cash	244.08	243.67	-0.17
Capex	-3.52	-4.51	-28.31
Free Cash Flow	22.19	4.20	-81.06
Revenue	103.43	89.81	-13.16
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.80	1.77	-1.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.93	-3.10	-60.62
Naive Interpretation	Member

06 - Financial Health · Weak

Rating